Answers are grounded in this paper and cite their sources.
In Brief Enhanced external counterpulsation (EECP) is a noninvasive treatment for patients with coronary artery disease who have angina pectoris that is refractory to pharmacotherapy and revascularization. The popular concept is that EECP may promote collateral development and improve myocardial perfusion. We hypothesize that improvements in peripheral arterial function are responsible for the clinical benefits of EECP. Enhanced external counterpulsation is treatment for angina pectoris. We hypothesize that improvements in peripheral arterial function create the clinical benefits.
No takes yet. Share an insight, caveat, or question.
Braith et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: